Karin Heidemann
Chief Tech/Sci/R&D Officer at CHAMPIONS ONCOLOGY, INC.
Karin Heidemann active positions
Companies | Position | Start | End |
---|---|---|---|
CHAMPIONS ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | 2019-08-31 | - |
Career history of Karin Heidemann
Former positions of Karin Heidemann
Companies | Position | Start | End |
---|---|---|---|
Rockland Immunochemicals, Inc.
Rockland Immunochemicals, Inc. BiotechnologyHealth Technology Rockland Immunochemicals, Inc. is a biotech company that was founded in 1962. The private company is based in Limerick, PA and has subsidiaries in the United States and Germany. The company specializes in manufacturing cutting-edge tools for basic, applied, and clinical research. The company offers custom anti-id antibodies for specific therapeutic development and tissue powders that can be used as a specific adsorbent to remove unwanted reactivities or as source material. The CEO of Rockland Immunochemicals is James Fendrick. | Corporate Officer/Principal | 2017-02-28 | 2019-08-31 |
Training of Karin Heidemann
Universität zu Köln | Undergraduate Degree |
Statistics
International
United States | 3 |
Germany | 2 |
Operational
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
CHAMPIONS ONCOLOGY, INC. | Health Technology |
Private companies | 1 |
---|---|
Rockland Immunochemicals, Inc.
Rockland Immunochemicals, Inc. BiotechnologyHealth Technology Rockland Immunochemicals, Inc. is a biotech company that was founded in 1962. The private company is based in Limerick, PA and has subsidiaries in the United States and Germany. The company specializes in manufacturing cutting-edge tools for basic, applied, and clinical research. The company offers custom anti-id antibodies for specific therapeutic development and tissue powders that can be used as a specific adsorbent to remove unwanted reactivities or as source material. The CEO of Rockland Immunochemicals is James Fendrick. | Health Technology |
- Stock Market
- Insiders
- Karin Heidemann
- Experience